![](./media_1691e0dd0426af10e5e0f9b3380810ad88e898bf1.png?width=750&format=png&optimize=medium)
Zelta eCOA/ePRO: Boost patient engagement
- Data gathered directly from participants, including diaries, surveys, and assessments, is instantly available in Zelta EDC.
- Improve patient experience and adherence with an ePRO app that’s convenient and easy to use via mobile (iOS or Android) or web.
- Reach participants and sites anywhere in the world.
Zelta eConsent: Quickly consent participants wherever they are
- Maximize site efficiency and remote management of participant consent.
- Manage eConsent directly from Zelta’s cloud-based platform, alongside the eCOA/ePRO module.
- Track amendments, consent status, and timelines in a dedicated dashboard.
- Increase participant convenience with single sign-on access to both eConsent and eCOA/ePRO.
![](./media_150debc76f97fec300d49b707f9dd6ed2b859162f.png?width=750&format=png&optimize=medium)
![](./media_128502ae5447580011782ee53b2f5e942424abbb1.png?width=750&format=png&optimize=medium)
Decentralized trials
eCOA and ePRO unleash the benefits of decentralized trials
Decentralized clinical trials (DCTs) offer several benefits for CROs and sponsor companies, including reduced need for site travel, lowered trial costs, and better patient-reported outcome data for analysis.
Enabling trial participants to report outcomes via ePRO or using eConsent can greatly improve the patient experience, boost recruitment for trial managers, and allow real-time data capture. To date, the Zelta platform – including eCOA, ePRO, eConsent, and other modules – has been used to successfully build, run, and support over 250 hybrid trials or DCTs.